trial

Neuromodulation in Depressed and Schizophrenic Patients - Changing MEP (Muscle Evoked Potentials) by tDCS (Transcranial Direct Current Stimulation)

NCTId NCT01150734
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase — · Completed
Enrollment 30 (actual)
Sponsored by Ludwig-Maximilians - University of Munich
Primary completion 2010-12
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
30 (actual)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2009-10
Primary completion
2010-12
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
—

Sponsors

Ludwig-Maximilians - University of MunichLead Sponsor

Investigators

1
Frank Padberg, Prof. Dr.Study Director

Sites

1 total
Munich, Germany

Facts & assertions

4 sourced
Enrollment
30
Phase
NA
Primary Completion Date
2010-12
Status
COMPLETED
relationships
The graph out of here
lead_sponsor
Ludwig-Maximilians - University of Munich
company
indication
Schizophrenia
indication
Depression
indication
Schizophrenia
indication
investigator
Frank Padberg, Prof. Dr.
person